Percutaneous Ultrasound-Guided Ablation of Implanted Parathyroid Glands for Recurrent Hyperparathyroidism After Total Parathyroidectomy
Journal of Clinical Medicine · 03.07.2026 · 15 (13) · 5211
DOI: 10.3390/jcm15135211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.07.2026. Verfasst von Guanqi Hang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore 169608, Singapore. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Tertiary hyperparathyroidism is a frequent complication of end-stage kidney disease that may require parathyroidectomy when medical therapy fails. Recurrent hyperparathyroidism may occur after total parathyroidectomy with autotransplantation. This study assessed the safety, feasibility, and efficacy of percutaneous ultrasound-guided ablation for implanted parathyroid glands in patients with recurrent disease after total parathyroidectomy with autotransplantation. Materials and Methods: Eleven patients with recurrent hyperparathyroidism following total parathyroidectomy with autotransplantation who underwent percutaneous ultrasound-guided ablation were retrospectively reviewed. Pre- and post-procedure serum intact parathyroid hormone, calcium, phosphate, and alkaline phosphatase levels were extracted from electronic medical records and analyzed. Ablation modalities used in the study included radiofrequency ablation, microwave ablation, and cryoablation. Procedure-related complications were recorded. Patients were followed for 12 months with serial biomarker monitoring. Technical success was defined as ≥80% ablation of implanted parathyroid glands, and clinical success as meeting at least two of the following: (1) >50% intact parathyroid hormone reduction, (2) correction of hypercalcemia, (3) discontinuation of calcimimetic therapy.
Results
Technical success was achieved in 10 of 11 (90.9%) patients; one patient had incomplete ablation due to proximity of the gland to the skin. Among technically successful cases, all (100%) achieved clinical success, showing marked decreases in intact parathyroid hormone, normalization of calcium and phosphate, and reduced calcimimetic use. Transient hypocalcemia occurred in six patients, five requiring intravenous calcium replacement. No long-term complications were observed.
Conclusions
Percutaneous ultrasound-guided ablation of implanted parathyroid glands is a safe and effective option for managing recurrent hyperparathyroidism, offering a viable alternative to surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore 169608, Singapore.
- Department of Renal Medicine, Singapore General Hospital, Singapore 169608, Singapore.
ORCID-Profile: Jiunn Wong
Zitieren
APA
Hang, G., Wong, J., Leong, S., Andres, J., Lee, W., & Too, C. W. (2026). Percutaneous Ultrasound-Guided Ablation of Implanted Parathyroid Glands for Recurrent Hyperparathyroidism After Total Parathyroidectomy. Journal of Clinical Medicine, 15(13), 5211. https://doi.org/10.3390/jcm15135211
Vancouver
Hang G, Wong J, Leong S, Andres J, Lee W, Too CW. Percutaneous Ultrasound-Guided Ablation of Implanted Parathyroid Glands for Recurrent Hyperparathyroidism After Total Parathyroidectomy. Journal of Clinical Medicine. 2026;15(13):5211. doi:10.3390/jcm15135211
BibTeX
@article{Hang2026,
author = {Hang, Guanqi and Wong, Jiunn and Leong, Sum and Andres, Julia and Lee, Weiyong and Too, Chow Wei},
title = {Percutaneous Ultrasound-Guided Ablation of Implanted Parathyroid Glands for Recurrent Hyperparathyroidism After Total Parathyroidectomy},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {5211},
doi = {10.3390/jcm15135211}
}
EUVIMED